West Lafayette-based Bioanalytical Systems’ latest executive departure comes amid recent signs of stability, turnaround and growth for a company that just three years ago was on the verge of sinking.
Subaru pressing ahead with plans for $158M expansion in Lafayette
The automaker, which announced its expansion plans just weeks before COVID-19 began disrupting the economy, says the project won’t be affected by the pandemic.Read More
Discount retailer with 8 central Indiana stores files for bankruptcy, seeks buyer
Store closures due to the coronavirus crisis undermined the department store chain’s parent company and its ability to get financing to continue operations.Read More
Purdue found a fountain of new revenue last fall at Ross-Ade Stadium, after alcohol sales were expanded to the entire stadium.
St. Vincent Health will close its long-term acute hospital in Lafayette in the next two months, leaving as many as 83 workers without jobs. St. Vincent will continue to operate its other Seton Specialty Hospital in Indianapolis.
Endocyte Inc. will submit its ovarian cancer drug EC145 for European market approval in the third quarter of this year after the European Commission granted it orphan drug status.
In the last 10 years, Indiana’s major research universities—Indiana and Purdue—have nearly doubled their
science-based research budgets, to a total of $895 million. Yet Indiana’s public universities still run in the middle
of the pack nationally.
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
Purdue University will join the quest for cheap solar-generated electricity with an initiative aimed at speeding up research
across the industry. The Network for Photovoltaic Technology will launch this fall, focused on creating computer models to
eliminate costly and slow trial-and-error research in the solar industry.
Bioanalytical Systems Inc. narrowed its losses in the second fiscal quarter despite a 2 percent drop in revenue, the West
Lafayette-based contract research firm said late last week.